547 results on '"Klivényi, Péter"'
Search Results
152. Postnatal outcome and placental blood flow after plasmapheresis during pregnancy
153. Different phenotypes in identical twins with cerebrotendinous xanthomatosis: case series
154. Effect of subthalamic stimulation on distal and proximal upper limb movements in Parkinson's disease
155. Electron Transport Disturbances and Neurodegeneration: From Albert Szent-Györgyi’s Concept (Szeged) till Novel Approaches to Boost Mitochondrial Bioenergetics
156. AZ MDS-UPDRS MAGYAR VALIDÁCIÓJA: MIÉRT SZÜKSÉGES ÚJABB PARKINSON-PONTOZÓSKÁLA?
157. The Role of Cerebrospinal Fluid Biomarkers in the Evolution of Diagnostic Criteria in Alzheimer’s Disease: Shortcomings in Prodromal Diagnosis
158. Inhibitors of the kynurenine pathway as neurotherapeutics: a patent review (2012–2015)
159. An assessment of the frequency of mutations in the GBA and VPS35 genes in Hungarian patients with sporadic Parkinson’s disease
160. GENETICALLY DETERMINED DISEASES ASSOCIATED WITH PATHOLOGICAL BRAIN IRON ACCUMULATION AND NEURODEGENERATION
161. Unilateral thalamic infarction causing downward gaze palsy in a patient with uncorrected tetralogy of Fallot: a case report = A lefelé tekintés bénulását okozó egyoldali thalamusinfarktus Fallot-tetralógia nem korrigált formájával élő felnőttnél: esetismertetés
162. Ajánlás a Parkinson-kór előrehaladott stádiumának kezeléséhez
163. High-dose 1,25-dihydroxyvitamin D supplementation elongates the lifespan of Huntington's disease transgenic mice
164. Independent validation of Parkinson’s disease Sleep Scale 2nd version (PDSS-2)
165. Myasthenia gravis miatt végzett három különböző típusú csecsemőmirigy-eltávolítás sebészeti és korai neurológiai eredményei
166. The rs13388259 Intergenic Polymorphism in the Genomic Context of the BCYRN1 Gene Is Associated with Parkinson’s Disease in the Hungarian Population.
167. Postnatal outcome and placental blood flow after plasmapheresis during pregnancy.
168. Indoleamine 2,3-dioxygenase as a novel therapeutic target for Huntington’s disease
169. Language deficits in pre-symptomatic Huntington’s disease: Evidence from Hungarian
170. The clinical manifestations of two novel SPAST mutations
171. Drug-induced movement disorders
172. Validation of the Hungarian Unified Dyskinesia Rating Scale
173. The Genetic Link between Parkinson’s Disease and the Kynurenine Pathway Is Still Missing
174. mRNA Expression Levels of PGC-1α in a Transgenic and a Toxin Model of Huntington’s Disease
175. CEREBROSPINAL FLUID LIPIDOMIC PROFILE IN ALZHEIMER’S DISEASE
176. B7 costimulation and intracellular indoleamine-2,3-dioxygenase (IDO) expression in peripheral blood of healthy pregnant and non-pregnant women
177. The role of cognitive training in the neurorehabilitation of a patient who survived a lightning strike. A case study
178. Glutamatergic Dysfunctioning in Alzheimer's Disease and Related Therapeutic Targets
179. Is the MDS-UPDRS a Good Screening Tool for Detecting Sleep Problems and Daytime Sleepiness in Parkinson’s Disease?
180. High-dose 1,25-dihydroxyvitamin D supplementation elongates the lifespan of Huntington's disease transgenic mice.
181. Independent validation of Parkinson's disease Sleep Scale 2nd version (PDSS-2).
182. Some molecular mechanisms of dopaminergic and glutamatergic dysfunctioning in Parkinson’s disease
183. Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: Novel therapeutic strategies for neurodegenerative disorders
184. Neuroprotection by Kynurenine Metabolites.
185. Frontal two-electrode transcranial direct current stimulation protocols may not affect performance on a combined flanker Go/No-Go task.
186. Target Identification for Stereotactic Thalamotomy Using Diffusion Tractography
187. Real-world operation of multiple sclerosis centres in Central-Eastern European countries covering 107 million inhabitants
188. Kynurenines in Parkinson’s disease: therapeutic perspectives
189. A new myelin protein, TPPP/p25, reduced in demyelinated lesions is enriched in cerebrospinal fluid of multiple sclerosis
190. Targeting the Kynurenine Pathway-Related Alterations in Alzheimer's Disease: A Future Therapeutic Strategy
191. The Report of p.Val717Phe Mutation in the APP Gene in a Hungarian Family With Alzheimer Disease: A Phenomenological Study.
192. The Report of p.Val717Phe Mutation in the APP Gene in a Hungarian Family With Alzheimer Disease:A Phenomenological Study.
193. mRNA Expression Levels of PGC-1α in a Transgenic and a Toxin Model of Huntington's Disease.
194. The Prevalence of Multiple Sclerosis, Distribution of Clinical Forms of the Disease and Functional Status of Patients in Csongrád County, Hungary
195. Different phenotypes in identical twins with cerebrotendinous xanthomatosis: case series.
196. B7 costimulation and intracellular indoleamine-2, 3-dioxygenase (IDO) expression in peripheral blood of healthy pregnant and non-pregnant women.
197. Targeting the Kynurenine Pathway-Related Alterations in Alzheimer's Disease: A Future Therapeutic Strategy.
198. The effect of computerized cognitive training and transcranial direct current stimulation on working memory among post-stroke individuals: a systematic review with meta-analysis and meta-regression.
199. The Application of Goal Attainment Scaling in Cervical Dystonia – An Exploratory Observational Pilot Study.
200. The 7-year follow-up of the Hungarian BICAMS validation cohort implies that cognitive performance may improve in multiple sclerosis patients.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.